Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series

被引：0
|
作者：
Frank B. Cortazar
David E. Leaf
Charles T. Owens
Karen Laliberte
William F. Pendergraft
John L. Niles
机构：
[1] Massachusetts General Hospital,Vasculitis and Glomerulonephritis Center, Division of Nephrology
[2] Brigham and Women’s Hospital,Division of Renal Medicine
[3] Baylor University Medical Center at Dallas,Division of Nephrology
[4] University of North Carolina Kidney Center,Division of Nephrology and Hypertension, Department of Medicine
来源：
BMC Nephrology | / 18卷
关键词：
Membranous nephropathy; Cyclophosphamide; Rituximab; Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy
    Zou, Honghong
    Jiang, Fang
    Xu, Gaosi
    RENAL FAILURE, 2019, 41 (01) : 673 - 681
  • [32] Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy
    Zou, Honghong
    Jiang, Fang
    Xu, Gaosi
    INTERNAL MEDICINE JOURNAL, 2020, 50 (05) : 612 - 619
  • [33] A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
    Tassiulas, IO
    Boumpas, DT
    Vaughan, E
    Fleisher, TA
    Piscetelli, S
    Kim, Y
    Puccino, F
    Balow, JE
    Austin, HA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2679 - A2679
  • [34] Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study
    Fervenza, Fernando C.
    Abraham, Roshini S.
    Erickson, Stephen B.
    Irazabal, Maria Valentina
    Eirin, Alfonso
    Specks, Ulrich
    Nachman, Patrick H.
    Bergstralh, Eric J.
    Leung, Nelson
    Cosio, Fernando G.
    Hogan, Marie C.
    Dillon, John J.
    Hickson, LaTonya J.
    Li, Xujian
    Cattran, Daniel C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (12): : 2188 - 2198
  • [35] Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience
    Katsuno, Takayuki
    Ozaki, Takenori
    Kim, Hangsoo
    Kato, Noritoshi
    Suzuki, Yasuhiro
    Akiyama, Shinichi
    Ishimoto, Takuji
    Kosugi, Tomoki
    Tsuboi, Naotake
    Ito, Yasuhiko
    Maruyama, Shoichi
    INTERNAL MEDICINE, 2017, 56 (13) : 1679 - 1686
  • [36] Predictive factors of response to steroids and cyclophosphamide therapy in idiopathic membranous nephropathy
    李舒
    China Medical Abstracts(Internal Medicine), 2016, 33 (01) : 49 - 49
  • [37] New-Onset Diabetes Mellitus in Patients with Idiopathic Membranous Nephropathy Undergoing Tacrolimus and Low-Dose Corticosteroid Therapy
    Shao, Lina
    Jin, Juan
    Ye, Binxian
    Xu, Baihui
    Li, Yiwen
    Gong, Jianguang
    Zhang, Jiong
    Chen, Maosheng
    He, Qiang
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (06): : 1352 - 1362
  • [38] Combining Low-Dose Rituximab and Bortezomib as Immunosuppressive Therapy for Acquired Hemophilia A: 6 Case Series
    Yuhan Fu
    Shu Chen
    Anzi Wang
    Jingyuan Luo
    Qing Li
    Indian Journal of Hematology and Blood Transfusion, 2024, 40 : 157 - 160
  • [39] Combining Low-Dose Rituximab and Bortezomib as Immunosuppressive Therapy for Acquired Hemophilia A: 6 Case Series
    Fu, Yuhan
    Chen, Shu
    Wang, Anzi
    Luo, Jingyuan
    Li, Qing
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (01) : 157 - 160
  • [40] RITUXIMAB THERAPY FOR PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY RESISTANT TO CALCINEURIN INHIBITOR BASED THERAPY
    Sacli, Sevgi
    Akyildiz, Arif
    Ucar, Ali Riza
    Demir, Erol
    Yazici, Halil
    Turkmen, Aydin
    Caliskan, Yasar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 506 - 506
12345